title: Harm associated with 6 % tetrastarch 130 kDa [hydroxyethyl starch (HES) 130/0.4 and 130/0.42] is robust to sensitivity analysis by excluding Dolecek et al.
authors.forename: Amit
authors.initials: A
authors.lastname: Patel
authors.forename: Umeer
authors.initials: U
authors.lastname: Waheed
authors.forename: Stephen J
authors.initials: SJ
authors.lastname: Brett
mesh_terms: D005440:Fluid Therapy / Q000379:methods*; D006801:Humans; D006895:Hydroxyethyl Starch Derivatives / Q000009:adverse effects*; D010952:Plasma Substitutes / Q000009:adverse effects*; D018805:Sepsis / Q000401:mortality* / Q000628:therapy*
chemical_list: D006895:Hydroxyethyl Starch Derivatives; D010952:Plasma Substitutes